Enovis ENOV
NYSE ENOV
$18.65 -0.38 (-2.00%)
As of: Sep 10, 2026 · 10:50 AM EDT

Enovis (ENOV) Non-Current Assets (2010 - 2026)

Enovis' (ENOV) quarterly Non-Current Assets came in at $2.6 billion in Q3 2026, down 31.8% year-over-year from $3.7 billion in Q3 2025, and down 1.59% quarter-over-quarter from $2.6 billion in Q2 2026.

Analysis

Enovis (ENOV) Non-Current Assets (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Non-Current Assets for 17 consecutive years, with $2.6 billion the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Non-Current Assets fell 31.8% year-over-year to $2.6 billion in Q3 2026; TTM through Jul 2026 was $10.9 billion, a 28.68% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 26.44% from the prior year.
  • Non-Current Assets was $2.6 billion for Q3 2026 at Enovis, down from $2.6 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $6.1 billion in Q2 2022 and troughed at $2.6 billion in Q3 2026.
  • A 5-year average of $3.6 billion and a median of $3.6 billion in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets tumbled 44.98% in 2022 and advanced 24.85% in 2024, its largest moves.
  • Over 5 years, Non-Current Assets stood at $3.5 billion in 2022, then grew by 3.87% to $3.6 billion in 2023, then decreased by 1.12% to $3.6 billion in 2024, then slipped by 26.44% to $2.6 billion in 2025, then slipped by 2.9% to $2.6 billion in 2026.
  • The last three Non-Current Assets figures came in at $2.6 billion (Q3 2026), $2.6 billion (Q2 2026), and $2.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 181.92 Bn 176.31 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 127.64 Bn 122.42 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.92 Bn 109.10 Bn 6.34 Bn 68.92 Bn
4 Stryker 105.39 Bn 101.91 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 64.88 Bn 64.34 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.92 Bn 45.66 Bn 1.35 Bn 7.05 Bn
7 Alcon 33.24 Bn 31.79 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.12 Bn 30.18 Bn 830.00 Mn 2.37 Bn
9 Steris 20.83 Bn 20.35 Bn 684.20 Mn 8.29 Bn
10 Enovis 1.08 Bn 1.06 Bn 359.25 Mn 2.55 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 2.55 Bn
Apr 3, 2026 2.59 Bn
Dec 31, 2025 2.63 Bn
Oct 3, 2025 3.15 Bn
Jul 4, 2025 3.74 Bn
Apr 4, 2025 3.66 Bn
Dec 31, 2024 3.57 Bn
Sep 27, 2024 4.35 Bn
Jun 28, 2024 4.27 Bn
Mar 29, 2024 4.33 Bn
Dec 31, 2023 3.61 Bn
Sep 29, 2023 3.55 Bn
Jun 30, 2023 3.56 Bn
Mar 31, 2023 3.47 Bn
Dec 31, 2022 3.48 Bn
Sep 30, 2022 3.44 Bn
Jul 1, 2022 3.43 Bn
Apr 1, 2022 6.14 Bn
Dec 31, 2021 6.21 Bn
Oct 1, 2021 6.25 Bn